SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $953,469 | -92.8% | 41,240 | -92.0% | 0.00% | -93.3% |
Q1 2023 | $13,290,900 | -22.6% | 516,352 | -21.7% | 0.02% | -25.0% |
Q4 2022 | $17,161,737 | -35.8% | 659,813 | -29.6% | 0.02% | -35.5% |
Q3 2022 | $26,725,000 | +10.8% | 936,747 | -4.4% | 0.03% | +14.8% |
Q2 2022 | $24,117,000 | -45.3% | 979,594 | +25.2% | 0.03% | -38.6% |
Q1 2022 | $44,074,000 | -8.2% | 782,117 | +1.0% | 0.04% | 0.0% |
Q4 2021 | $47,990,000 | -8.8% | 774,274 | -6.6% | 0.04% | -15.4% |
Q3 2021 | $52,604,000 | -26.8% | 829,185 | -5.0% | 0.05% | -24.6% |
Q2 2021 | $71,907,000 | +15.6% | 872,562 | +3.2% | 0.07% | +7.8% |
Q1 2021 | $62,187,000 | +32.4% | 845,265 | +30.5% | 0.06% | +23.1% |
Q4 2020 | $46,986,000 | +81.5% | 647,904 | +19.3% | 0.05% | +57.6% |
Q3 2020 | $25,884,000 | +1391.0% | 542,984 | +1213.5% | 0.03% | +1550.0% |
Q2 2020 | $1,736,000 | -77.7% | 41,340 | -85.7% | 0.00% | -71.4% |
Q1 2020 | $7,794,000 | +37.9% | 288,658 | +96.6% | 0.01% | 0.0% |
Q4 2019 | $5,653,000 | +49.0% | 146,859 | -16.1% | 0.01% | +40.0% |
Q3 2019 | $3,794,000 | – | 175,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |